National Bank of Canada’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.8K | Hold |
410
| – | – | ﹤0.01% | 1766 |
|
|
2025
Q1 | $28.9K | Hold |
410
| – | – | ﹤0.01% | 1694 |
|
|
2024
Q4 | $26.9K | Sell |
410
-28
| -6% | -$1.84K | ﹤0.01% | 1742 |
|
|
2024
Q3 | $30.9K | Sell |
438
-30
| -6% | -$2.12K | ﹤0.01% | 1650 |
|
|
2024
Q2 | $31K | Hold |
468
| – | – | ﹤0.01% | 1690 |
|
|
2024
Q1 | $30.5K | Sell |
468
-93
| -17% | -$6.07K | ﹤0.01% | 1722 |
|
|
2023
Q4 | $35K | Buy |
561
+411
| +274% | +$25.7K | ﹤0.01% | 1707 |
|
|
2023
Q3 | $8.71K | Hold |
150
| – | – | ﹤0.01% | 2000 |
|
|
2023
Q2 | $8.94K | Sell |
150
-45
| -23% | -$2.68K | ﹤0.01% | 2046 |
|
|
2023
Q1 | $11.4K | Hold |
195
| – | – | ﹤0.01% | 1963 |
|
|
2022
Q4 | $12.1K | Sell |
195
-27
| -12% | -$1.67K | ﹤0.01% | 1964 |
|
|
2022
Q3 | $12K | Hold |
222
| – | – | ﹤0.01% | 1964 |
|
|
2022
Q2 | $14K | Hold |
222
| – | – | ﹤0.01% | 1964 |
|
|
2022
Q1 | $14K | Buy |
222
+96
| +76% | +$6.05K | ﹤0.01% | 2040 |
|
|
2021
Q4 | $8K | Buy |
+126
| New | +$8K | ﹤0.01% | 2193 |
|